BACKGROUND: Obstructive sleep apnea (OSA) is an important and common comorbidity in patients with chronic kidney disease (CKD). However, few studies have addressed how OSA presents in this patient population and whether it is clinically apparent. OBJECTIVE: The objectives of this study were to determine if the prevalence and severity of sleep related symptoms distinguished CKD patients with OSA from those without apnea, and whether the clinical presentation of OSA in CKD patients differed from the general OSA population. METHODS: One hundred nineteen patients were recruited from outpatient nephrology clinics. All patients completed a sleep history questionnaire, the Epworth Sleepiness Scale (daytime sleepiness, ESS > 10), the Pittsburgh Sleep Quality Index (poor sleep quality, PSQI > 5), and underwent overnight cardiopulmonary monitoring for determination of sleep apnea (respiratory disturbance index ≥ 15). CKD patients with OSA (n = 46) were compared to (1) CKD patients without OSA (n = 73) and (2) OSA patients without CKD (n = 230) who were referred to the sleep centre. RESULTS: The prevalence of OSA symptoms and PSQI scores did not differ between CKD patients with OSA and CKD patients without apnea. Although the prevalence of daytime sleepiness was higher in CKD patients with OSA compared to CKD patients without apnea (39% vs. 19%, p = 0.033), both daytime sleepiness and other symptoms of sleep apnea were considerably less frequent than in OSA patients without a history of kidney disease. CONCLUSIONS: The presence of OSA in patients with CKD is unlikely to be clinically apparent. Consequently, objective cardiopulmonary monitoring during sleep is required to reliably identify this comorbidity.
BACKGROUND:Obstructive sleep apnea (OSA) is an important and common comorbidity in patients with chronic kidney disease (CKD). However, few studies have addressed how OSA presents in this patient population and whether it is clinically apparent. OBJECTIVE: The objectives of this study were to determine if the prevalence and severity of sleep related symptoms distinguished CKDpatients with OSA from those without apnea, and whether the clinical presentation of OSA in CKDpatients differed from the general OSA population. METHODS: One hundred nineteen patients were recruited from outpatient nephrology clinics. All patients completed a sleep history questionnaire, the Epworth Sleepiness Scale (daytime sleepiness, ESS > 10), the Pittsburgh Sleep Quality Index (poor sleep quality, PSQI > 5), and underwent overnight cardiopulmonary monitoring for determination of sleep apnea (respiratory disturbance index ≥ 15). CKDpatients with OSA (n = 46) were compared to (1) CKDpatients without OSA (n = 73) and (2) OSA patients without CKD (n = 230) who were referred to the sleep centre. RESULTS: The prevalence of OSA symptoms and PSQI scores did not differ between CKDpatients with OSA and CKDpatients without apnea. Although the prevalence of daytime sleepiness was higher in CKDpatients with OSA compared to CKDpatients without apnea (39% vs. 19%, p = 0.033), both daytime sleepiness and other symptoms of sleep apnea were considerably less frequent than in OSA patients without a history of kidney disease. CONCLUSIONS: The presence of OSA in patients with CKD is unlikely to be clinically apparent. Consequently, objective cardiopulmonary monitoring during sleep is required to reliably identify this comorbidity.
Authors: John J Sim; Scott A Rasgon; Dean A Kujubu; Victoria A Kumar; In Lu A Liu; Jiaxiao M Shi; Tam T Pham; Stephen F Derose Journal: Chest Date: 2008-11-24 Impact factor: 9.410
Authors: Miguel Gus; Sandro C Gonçalves; Denis Martinez; Erlon O de Abreu Silva; Leila B Moreira; Sandra C Fuchs; Flávio D Fuchs Journal: Am J Hypertens Date: 2008-05-01 Impact factor: 2.689
Authors: James P Lash; Alan S Go; Lawrence J Appel; Jiang He; Akinlolu Ojo; Mahboob Rahman; Raymond R Townsend; Dawei Xie; Denise Cifelli; Janet Cohan; Jeffrey C Fink; Michael J Fischer; Crystal Gadegbeku; L Lee Hamm; John W Kusek; J Richard Landis; Andrew Narva; Nancy Robinson; Valerie Teal; Harold I Feldman Journal: Clin J Am Soc Nephrol Date: 2009-06-18 Impact factor: 8.237
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Jonathan Lee; Tanvir C Turin; David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Abul K Azad; Patrick J Hanly Journal: Sleep Breath Date: 2014-11-05 Impact factor: 2.816
Authors: David D M Nicholl; Sofia B Ahmed; Andrea H S Loewen; Brenda R Hemmelgarn; Darlene Y Sola; Jaime M Beecroft; Tanvir C Turin; Patrick J Hanly Journal: J Clin Sleep Med Date: 2013-01-15 Impact factor: 4.062
Authors: Valentina Forni Ogna; Adam Ogna; Menno Pruijm; Isabelle Bassi; Emilie Zuercher; Georges Halabi; Olivier Phan; Roberto Bullani; Daniel Teta; Thierry Gauthier; Anne Cherpillod; Claudine Mathieu; Alexandra Mihalache; Francoise Cornette; José Haba-Rubio; Michel Burnier; Raphaël Heinzer Journal: Biomed Res Int Date: 2015-07-01 Impact factor: 3.411